Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.

Article Details

Citation

Copy to clipboard

Simmons KB, Haddad LB, Nanda K, Curtis KM

Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.

BJOG. 2018 Jun;125(7):804-811. doi: 10.1111/1471-0528.15027. Epub 2017 Dec 15.

PubMed ID

29130574 [ View in PubMed

]

Abstract

BACKGROUND: Rifamycin antibiotics are commonly used for treatment of tuberculosis, but may reduce the effectiveness of hormonal contraception (HC). OBJECTIVES: To determine whether interactions between rifamycins and HC result in decreased effectiveness or increased toxicity of either therapy. SEARCH STRATEGY: We searched MEDLINE, Embase, Cochrane and clinicaltrials.gov through May 2017. SELECTION CRITERIA: We included trials, cohort, and case-control studies addressing pregnancy rates, pharmacodynamics or pharmacokinetic (PK) outcomes when HC and rifamycins were administered together versus apart. Of 7291 original records identified, 11 met inclusion criteria after independent review by two authors. DATA COLLECTION AND ANALYSIS: Two authors independently abstracted study details and assessed study quality using the United States Preventive Services Task Force grading system. Findings are reported descriptively. MAIN RESULTS: Studies only addressed combined oral contraceptives (COCs) and none reported pregnancy rates. Quality ranged from good to poor. Rifampin increased the frequency of ovulation in two of four studies, and reduced estrogen and/or progestin exposure in five studies. Rifabutin led to smaller PK changes than rifampin in two studies. In one study each, rifaximin and rifalazil did not alter hormone PK. CONCLUSIONS: No studies evaluated pregnancy risk or non-oral HCs. PK and ovulation outcomes support a clinically concerning drug interaction between COCs and rifampin, and to a lesser extent rifabutin. Data are limited for other rifamycins. TWEETABLE ABSTRACT: Rifampin and rifabutin reduce systemic exposure of oral contraceptives, but no studies have evaluated pregnancy risk.

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Chlormadinone	Cytochrome P450 3A4	Protein	Humans	No	Substrate	Details
Demegestone	Cytochrome P450 3A4	Protein	Humans	No	Substrate	Details
Quingestanol	Cytochrome P450 3A4	Protein	Humans	No	Substrate	Details

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Cyproterone acetate Piperacillin	The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Piperacillin.
Cyproterone acetate Ampicillin	The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Ampicillin.
Cyproterone acetate Phenoxymethylpenicillin	The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Phenoxymethylpenicillin.
Cyproterone acetate Carbenicillin	The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Carbenicillin.
Cyproterone acetate Oxacillin	The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Oxacillin.